Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Diabetes is defined by its association with hyperglycemia-specific microvascular complications; however, it also imparts a two- to fourfold risk of cardiovascular disease (CVD). Although microvascular complications can lead to significant morbidity and premature mortality, by far the greatest cause of death in people with diabetes is CVD. Results from randomized controlled trials have demonstrated conclusively that the risk of microvascular complications can be reduced by intensive glycemic control in patients with type 1 (1,2) and type 2 diabetes (3–5). In the Diabetes Control and Complications Trial (DCCT), there was an ∼60% reduction in development or progression of diabetic retinopathy, nephropathy, and neuropathy between the intensively treated group (goal A1C <6.05%, mean achieved A1C ∼7%) and the standard group (A1C ∼9%) over an average of 6.5 years. The relationship between glucose control (as reflected by the mean on-study A1C value) and risk of complications was log-linear and extended down to the normal A1C range (<6%) with no threshold noted. In the UK Prospective Diabetes Study (UKPDS), participants newly diagnosed with type 2 diabetes were followed for 10 years, and intensive control (median A1C 7.0%) was found to reduce the overall microvascular complication rate by 25% compared with conventional treatment (median A1C 7.9%). Here, too, secondary analyses showed a continuous relationship between the risk of microvascular complications and glycemia extending into the normal range of A1C, with no glycemic threshold. On the basis of these two large controlled trials, along with smaller studies and numerous epidemiologic reports, the consistent findings related to microvascular risk reduction with intensive glycemic control have led the American Diabetes Association (ADA) to recommend an A1C goal of <7% for most adults with diabetes (6), recognizing that more or less stringent goals may be appropriate for certain patients. Whereas many epidemiologic studies and meta-analyses …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“However, severe hypoglycemia may also be a marker of vulnerability, without any direct causal contribution to the increased mortality (72).”
From Hypoglycemia (2018) · cites this paper as [72]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,006
Research works printed but not linked: 1
- Duckworth W, Abraira C, Moritz T, Reda D, Emannele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vikek ME, Henderson WG, Huang GD: Intensive glucose control and complications in American veterans with type 2 diabetes. N Engl J Med. In press
Cited by
Items 401–500 of 879
Insulin Therapy in the Elderly Patient With Diabetes
Tanwani, L. K. (2011) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2011.02.006 · Cited by 23
Bailey, C. J., Blonde, L., Prato, S. D., Leiter, L. A., Nesto, R. W., & Management, G. P. F. E. D. (2009) · Diabetes and Vascular Disease Research · doi:10.1177/1479164109341691 · Cited by 20
Metabolic hypertension: concept and practice
Zhu, Z., Wang, P., & Ma, S. (2013) · Frontiers of Medicine · doi:10.1007/s11684-013-0264-4 · Cited by 19
Kadić, D., Hasić, S., & Spahić, E. (2015) · Medicinski Glasnik · doi:10.17392/843-16 · Cited by 19
Empagliflozin: Role in Treatment Options for Patients with Type 2 Diabetes Mellitus
Anderson, J. E., Wright, E. E., & Shaefer, C. F. (2016) · Diabetes Therapy · doi:10.1007/s13300-016-0211-x · Cited by 22
Chandra, N. C. (2021) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22840 · Cited by 21
Namba, M., Iwakura, T., Nishimura, R., Akazawa, K., Matsuhisa, M., Atsumi, Y., Satoh, J., & Yamauchi, T. (2018) · Diabetology International · doi:10.1007/s13340-018-0346-2 · Cited by 21
Yokoh, H., Kobayashi, K., Sato, Y., Takemoto, M., Uchida, D., Kanatsuka, A., Kuribayashi, N., Terano, T., Hashimoto, N., Sakurai, K., et al. (2014) · Journal of Diabetes Investigation · doi:10.1111/jdi.12282 · Cited by 20
Fadini, G. P., Albiero, M., & Avogaro, A. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.08.004 · Cited by 19
Individualizing treatment targets in diabetes care
Buse, J. B. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.230 · Cited by 18
Self-citationFang, Q., Shi, J., Zhang, J. Y., Peng, Y. H., Liu, C., Wei, X., Hu, Z., Sun, L., Hong, J., Gu, W., et al. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01884-7 · Cited by 23
When Metformin Fails in Type 2 Diabetes Mellitus
Esposito, K., Bellastella, G., & Giugliano, D. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.4 · Cited by 22
Hirsch, I. B., Amiel, S. A., Blumer, I. R., Bode, B. W., Edelman, S. V., Seley, J. J., Verderese, C. A., & Kilpatrick, E. S. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0132 · Cited by 18
Diabetes clinical trials: helped or hindered by the current shift in regulatory requirements?
Zannad, F. M., Stough, W. G., Pocock, S., Sleight, P., Cushman, W. C., Cleland, J. G. F., McMurray, J. J. V., Lonn, E., Geller, N. L., Wedel, H., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr437 · Cited by 19
Hsieh, M., Hsieh, Y., Cho, T., Chen, J., Lin, S.-D., Chen, H., & Tu, S. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2011.02479.x · Cited by 18
Mezquita‐Raya, P., Reyes‐García, R., Moreno, Ó., Muñoz‐Torres, M., Merino-Torres, J. F., Martínez, J. J. G., Jódar-Gimeno, E., Martín, J. E. S., Gargallo-Fernández, M., Soto-González, A., et al. (2013) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2013.11.009 · Cited by 27
Multiple HbA1c targets and insulin analogues in type 2 diabetes: a systematic review
Giugliano, D., Maiorino, M. I., Bellastella, G., Chiodini, P., & Esposito, K. (2011) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2011.03.005 · Cited by 19
Olsson, M., Schnecke, V., Cabrera, C. S., Skrtic, S., & Lind, M. (2015) · Diabetes Care · doi:10.2337/dc14-2351 · Cited by 17
Rubio, J. A., Jiménez, S., & Álvarez, J. (2017) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2017.02.012 · Cited by 21
Insulin detemir for the treatment of obese patients with type 2 diabetes
Hollander, P. A. (2012) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s26980 · Cited by 19
Balijepalli, C., Shirali, R., Kandaswamy, P., Ustyugova, A., Pfarr, E., Lund, S. S., & Druyts, E. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0456-7 · Cited by 17
Stolker, J. M., Sun, D., Conaway, D. G., Jones, P. G., Masoudi, F. A., Peterson, P. N., Krumholz, H. M., Kosiborod, M., & Spertus, J. A. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.12.010 · Cited by 19
Self-citationGagliardino, J. J., Kleinebreil, L., Colagiuri, S., Flack, J. R., Caporale, J., Siri, F., & Clark, C. M. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.12.024 · Cited by 16
The Effect of Blood Glucose Self-Monitoring Among Inmates With Diabetes
Buskey, R. H., Mathieson, K. M., Leafman, J. S., & Feinglos, M. N. (2015) · Journal of Correctional Health Care · doi:10.1177/1078345815599782 · Cited by 21
What can we learn from the recent blood glucose lowering megatrials?
Chan, J. C. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00063.x · Cited by 17
Effect of Hospital Admission on Glycemic Control 1 Year After Discharge
Wei, N. J., Grant, R. W., Nathan, D. M., & Wexler, D. J. (2012) · Endocrine Practice · doi:10.4158/ep11309.or · Cited by 19
Arrieta, F., Piñera, M., Iglesias, P., Nogales, P., Salinero-Fort, M. Á., Abanades, J. C., Botella-Carretero, J. I., Calañas, A., Balsa, J. A., Zamarrón, I., et al. (2013) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2013.09.002 · Cited by 17
Lam, K. S. L., Chow, C. C., Tan, K. C. B., Ronald, C. W., Kong, A. P. S., Tong, P. C. Y., Tsang, M. W., Chan, T. M., Tang, S. C. W., Lee, K. K., et al. (2016) · Current Medical Research and Opinion · doi:10.1185/03007995.2016.1161608 · Cited by 19
Taking hypoglycaemia seriously: diabetes, dementia and heart disease
Holt, P. (2011) · British Journal of Community Nursing · doi:10.12968/bjcn.2011.16.5.246 · Cited by 17
Peralta, F. G., Martín, F. J. E. S., Torre, E. L. M., Mata‐Cases, M., García, J. C. F., Loiola, P. E., Lachica, L. Á., Pérez, J. A. F., Menéndez, S. A., Guisasola, F. Á., et al. (2018) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2018.11.010 · Cited by 20
Elbalshy, M. M., Styles, S. E., Haszard, J. J., Galland, B. C., Crocket, H. R., Jefferies, C., Wiltshire, E. J., Tomlinson, P. A., de Bock, M. I., & Wheeler, B. J. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13331 · Cited by 20
Benardeau, A. M., Verry, P., Atzpodien, E., Funk, J., Meyer, M., Mizrahi, J. L., Winter, M., Wright, M. B., Uhles, S., & ŠEBÖKOVÁ, E. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12006 · Cited by 17
Natarajan, M. K., Strauss, B. H., Rokoss, M. J., Buller, C. E. H., Mancini, G. B. J., Xie, C., Sheth, T., Goodhart, D. M., Cohen, E. A., Seidelin, P. H., et al. (2012) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2011.12.001 · Cited by 16
Earle, N. J., Poppe, K., Doughty, R. N., Rolleston, A. K., Kerr, A., & Legget, M. E. (2017) · Heart Lung and Circulation · doi:10.1016/j.hlc.2017.04.010 · Cited by 18
Yang, W., Akhtar, S., Franek, E., Haluzík, M., Hirose, T., Kalyanam, B., Kar, S., Wu, T., Yavuz, D. G., & Unnikrishnan, A. (2022) · Diabetes Therapy · doi:10.1007/s13300-021-01196-7 · Cited by 16
Lee, H., Chan, Y., Chuang, C., Li, P., Yeh, Y., Hsiao, F., Peng, J., & See, L. (2023) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvad004 · Cited by 15
Gavin, J. R., STOLAR, M. W., Freeman, J. S., & Spellman, C. (2010) · PubMed · Cited by 20
Lynch, E. B., Liebman, R., Ventrelle, J., Keim, K. S., Appelhans, B. M., Avery, E., Tahsin, B., Li, H., Shapera, M., & Fogelfeld, L. A. (2014) · Contemporary Clinical Trials · doi:10.1016/j.cct.2014.09.003 · Cited by 16
The new NICE guidelines for type 2 diabetes – a critical analysis
O’Hare, J. P., Millar-Jones, D., Hanif, W., Hicks, D., Evans, M., Leslie, D., Bain, S. C., & Barnett, A. H. (2015) · The British Journal of Diabetes · doi:10.15277/bjdvd.2015.006 · Cited by 16
Park, C., Kang, J. G., Chon, S., Noh, J., Oh, S. J., Lee, C. B., & Park, S. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087799 · Cited by 19
Bozorgmanesh, M., Hadaegh, F., Sheikholeslami, F. H., Ghanbarian, A., & Azizi, F. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-69 · Cited by 16
Lynn, L. A., Hess, B., Weng, W., Lipner, R. S., & Holmboe, E. S. (2012) · Health Affairs · doi:10.1377/hlthaff.2011.0907 · Cited by 15
Meschia, J. F., Bushnell, C., Boden-Albala, B. M., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Fornage, M., Goldstein, L. B., et al. (2014) · Cited by 15
Evaluating Older Patients with Diabetes for Insulin Pump Therapy
Stephens, E. A., & Heffner, J. E. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0024 · Cited by 16
Bailey, R. A., Shillington, A. C., Harshaw, Q., Funnell, M. M., VanWingen, J., & Col, N. F. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0391-7 · Cited by 16
De-Intensification of Diabetes Treatment in Elderly Patients with Type 2 Diabetes Mellitus
Pírela, D., & Garg, R. (2019) · Endocrine Practice · doi:10.4158/ep-2019-0303 · Cited by 19
Li, S., Zheng, Z., Tang, X., Zhong, J., Liu, X., Zhao, Y., Chen, L., Zhu, J., Liu, J., & Chen, Y. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.12.006 · Cited by 14
Sullivan, S. D., Alfonso‐Cristancho, R., Conner, C., Hammer, M., & Blonde, L. (2009) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.11.1280 · Cited by 14
Diabetes Management in Long-Term Care Facilities: A Practical Guide
Meyers, R. M., & Reger, L. A. (2009) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2009.07.007 · Cited by 15
Understanding the Type 2 Diabetes Mellitus and Cardiovascular Disease Risk Paradox
Green, J. B. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.05.2767 · Cited by 16
Schernthaner, G., Lehmann, R., Prázný, M., Czupryniak, L., Ducena, K., Fasching, P., Janež, A., Karasik, A., Kempler, P., Martinka, E., et al. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0622-7 · Cited by 14
Pramanik, S., Mondal, S., Palui, R., & Ray, S. (2024) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v13.i2.91587 · Cited by 24
Block, C. E. M. D., Peleshok, J. C., Wilding, J. P. H., Kwan, A. Y. M., Rasouli, N., Maldonado, J. M., Wysham, C., Liu, M., Aleppo, G., & Benneyworth, B. D. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01660-0 · Cited by 16
The diabetes pandemic: is structured education the solution or an unnecessary expense?
Deakin, T. (2011) · Practical Diabetes · doi:10.1002/pdi.1635 · Cited by 17
Cardiovascular morbidity and mortality in diabetes mellitus: prediction and prognosis.
Astrup, A. S. (2011) · PubMed · Cited by 15
Schwartz, S. S., & Herman, M. E. (2015) · Postgraduate Medicine · doi:10.1080/00325481.2015.1043182 · Cited by 14
Korytkowski, M. T., & Forman, D. E. (2017) · Diabetes Care · doi:10.2337/dc16-0815 · Cited by 16
Pancholia, A. K. (2018) · Indian Heart Journal · doi:10.1016/j.ihj.2018.08.022 · Cited by 18
Rossiyskiy konsensus po terapii sakharnogo diabeta u detey i podrostkov
Dedov, I. I., Peterkova, V. A., & Кураева, Т. Л. (2010) · Diabetes Mellitus · doi:10.14341/2072-0351-6048 · Cited by 14
Gbadamosi, I. T., Adeyi, A. O., Oyekanmi, O. O., & Somade, O. T. (2020) · Metabolism Open · doi:10.1016/j.metop.2020.100029 · Cited by 13
Joy, T. M., Najeeb, S. S., Sreedevi, A., Vijayakumar, K., Syama, & Glycaemic Control and Determinants Team (2022) · Indian Journal of Public Health · doi:10.4103/ijph.ijph_1104_22 · Cited by 14
de Miguel-García, F., Merino-Senovilla, A., Montero-Alonso, M. J., Ortiz, A. G., Cantalapiedra, R. S., & Maderuelo-Fernández, J. Á. (2010) · Revista Española de Salud Pública · doi:10.1590/s1135-57272010000200006 · Cited by 13
Chang, C., Liao, K., Chang, Y., Wang, S., Chen, Y.-C., & Wang, G. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.03.002 · Cited by 13
Tunis, S. L. (2011) · Applied Health Economics and Health Policy · doi:10.2165/11594270-000000000-00000 · Cited by 14
Schwartz, S. S., Fabricatore, A. N., & Diamond, A. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5441-0_31 · Cited by 17
Chew, B., Ghazali, S. S., Lee, P. Y., Cheong, A. T., Mastura, I., Haniff, J., Bujang, M. A., Taher, S. W., & Mustapha, F. I. (2013) · PubMed · Cited by 13
Skrtic, S., Cabrera, C., Olsson, M., Schnecke, V., & Lind, M. (2017) · Heart · doi:10.1136/heartjnl-2016-309806 · Cited by 13
Clinical characteristics and mortality in patients treated in a Multidisciplinary Diabetic Foot Unit
Rubio, J. A., Jiménez, S., & Álvarez, J. (2017) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2017.02.013 · Cited by 13
Ramachandran, A., Jain, S. M., Mukherjee, S., Phatak, S., Pitale, S., Sk, S., Agrawal, N. K., Majumdar, A., Deshpande, N., Jhulka, S., et al. (2020) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018820937217 · Cited by 13
Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies
Schwartz, S. S. (2010) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmsott.s11389 · Cited by 16
Osteoarthritis progression: is diabetes a culprit?
Kirkman, M. S. (2015) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2015.03.030 · Cited by 13
Self-citationLega, I. C., Yale, J.-F., Chadha, A., Paty, B., Roscoe, R., Snider, M., Steier, J., Bajaj, H. S., Barnes, T., Gilbert, J., et al. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.08.003 · Cited by 12
Ribero, V. A., Efthimiou, O., Abolhassani, N., Alwan, H., Bauer, D. C., Henrard, S., Christiaens, A., O’Mahony, D., Knol, W., Peters, M. J. L., et al. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14340 · Cited by 12
Koivisto, V. A., Cleall, S., Pontiroli, A. E., & Giugliano, D. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01484.x · Cited by 12
Schiekofer, S., Bobak, I., Kleber, M. E., Maerz, W., Rudofsky, G., Dugi, K. A., & Schneider, J. G. (2013) · Diabetes and Vascular Disease Research · doi:10.1177/1479164113514232 · Cited by 12
Bays, H. E., Giezek, H., McKenney, J. M., O’Neill, E. A., & Tershakovec, A. M. (2012) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2012.0005 · Cited by 14
Lehrke, M., Leiter, L. A., Hehnke, U., Thiemann, S., Bhandari, A., Meinicke, T. W., & Johansen, O. E. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.06.015 · Cited by 13
Cardiovascular Risk Factor Status in Hospitalized Patients With Type 2 Diabetes in China
Yang, X., Liu, Q., Fan, Y., Ding, L., Wang, R., Hu, G., & Liu, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.664183 · Cited by 13
Fixed combination of repaglinide and metformin in the management of type 2 diabetes
Moses, R. G. (2009) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmsott.s4436 · Cited by 16
Roberts, A., Gohil, J., Hudson, L., Connolly, K., Warburton, P., Suman, R., O’Toole, P. J., O'Regan, D. J., Turner, N. A., Riches‐Suman, K., et al. (2015) · Journal of Diabetes Research · doi:10.1155/2015/409432 · Cited by 14
Quality of Care for Adult Type 2 Diabetes Mellitus at a University Primary Care Centre in Malaysia
Chew, B., Khoo, E. M., Chia, Y. C., & Lumpur, K. (2011) · Universiti Putra Malaysia Institutional Repository (Universiti Putra Malaysia) · Cited by 13
The Cutoff Value of HbA1c in Predicting Diabetes in Korean Adults in a University Hospital in Seoul
Bae, J. C., Rhee, E., Choi, E. S., Kim, J., Kim, W. J., Yoo, S. H., Park, S. E., Park, C., Lee, W., Oh, K. W., et al. (2009) · Korean Diabetes Journal · doi:10.4093/kdj.2009.33.6.503 · Cited by 12
Intensive glucose lowering treatment in type 2 diabetes
Preiss, D., & Ray, K. K. (2011) · BMJ · doi:10.1136/bmj.d4243 · Cited by 14
Doucet, J., Verny, C., Bordier, L., Rekik, A., Zulfiqar, A., Bezerra, C. B., & Bauduceau, B. (2020) · European Geriatric Medicine · doi:10.1007/s41999-020-00425-9 · Cited by 11
Xiang, Y., Ren, B., Chen, Y., Jiang, M., Wang, N., Niu, R. D., & Feng, B. (2021) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b20-00898 · Cited by 13
Lam, P. Y., Chow, S. C., Lam, W., Chow, L. L. W., & Fung, N. S. K. (2021) · Clinical ophthalmology · doi:10.2147/opth.s301317 · Cited by 15
Liang, B., Koye, D. N., Hachem, M., Zafari, N., Braat, S., & Ekinci, E. I. (2022) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2022.849725 · Cited by 13
Dedov, I. I., Shestakova, M. V., Абусуев, С. А., Valeeva, F. V., Verbovoy, A. F., Galstyan, G. R., Dogadin, S. A., Karpova, I. A., Mayorov, A. Y., Suntsov, Y. I., et al. (2010) · Diabetes Mellitus · doi:10.14341/2072-0351-6049 · Cited by 13
NICE guidelines for Type 2 diabetes: revised but still not fit for purpose
O’Hare, J. P., Hanif, W., Millar-Jones, D., Bain, S. C., Hicks, D., Leslie, R. D., & Barnett, A. H. (2015) · Diabetic Medicine · doi:10.1111/dme.12952 · Cited by 13
Erdoğan, D., Akçay, S., Yücel, H., Ersoy, İ. H., İçli, A., Kutlucan, A., Arslan, A., Yener, M., Özaydın, M., & Tamer, M. N. (2014) · Clinical Endocrinology · doi:10.1111/cen.12520 · Cited by 12
Overview of the Guidelines and Evidence for the Pharmacologic Management of Type 2 Diabetes Mellitus
Liday, C. (2011) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.31.12.37s · Cited by 11
Safety of Rapid-Acting Insulin Analogs Versus Regular Human Insulin
Kitabchi, A. E., & Gosmanov, A. R. (2012) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3182449ff9 · Cited by 11
Therapy to Obese Type 2 Diabetes Mellitus: How Far Will We Go Down the Wrong Road?
Heng, X.-P., Li, X., Li, L., Yang, L., Wang, Z.-T., & Huang, S.-P. (2018) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-018-3053-8 · Cited by 11
Bolli, G. B., Lucidi, P., Porcellati, F., & Fanelli, C. G. (2011) · Diabetes Care · doi:10.2337/dc11-s224 · Cited by 12
THE DIABETIC CKD PATIENT—A MAJOR CARDIOVASCULAR CHALLENGE
van der Meer, I. M., Ruggenenti, P. L., & Remuzzi, G. (2010) · Journal of Renal Care · doi:10.1111/j.1755-6686.2010.00165.x · Cited by 14
Bosevski, M., & Peovska, I. M. (2012) · Angiology · doi:10.1177/0003319711435936 · Cited by 11
Medical Management of the Patient with Intermittent Claudication
Vodnala, D., Rajagopalan, S., & Brook, R. D. (2011) · Cardiology Clinics · doi:10.1016/j.ccl.2011.04.003 · Cited by 12
Management of Acute Coronary Syndromes
Tardif, J., L'Allier, P. L., & FITCHETT, D. H. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.034 · Cited by 10
de Carvalho, L. S. F., Nogueira, A. C. C., Bonilha, I., Luchiari, B., Benchimol, A. K., Couri, C. E. B., Borges, J. L., Barreto, J., & Sposito, A. C. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.876795 · Cited by 13
Increased Carotid Thickness in Subjects with Recently-Diagnosed Diabetes from Rural Cameroon
Napoli, N., Zardi, E. M., Strollo, R., Arigliani, M., Daverio, A., Olearo, F., Tosi, D., Dicuonzo, G., Scarpa, F., Pedone, C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041316 · Cited by 11
Metadata
- Authors
- Skyler, J. S., Bergenstal, R., Bonow, R. O., Buse, J., Deedwania, P., Gale, E. A. M., Howard, B. V., Kirkman, M. S., Kosiborod, M., Reaven, P., & Sherwin, R. S.
- Affiliations
- University of Miami (US)
- Park Nicollet Clinic (US)
- Northwestern University (US)
- University of North Carolina at Chapel Hill (US)
- University of California, San Francisco (US)
- University of Bristol (GB)
- American Diabetes Association (US)
- Saint Luke's Hospital (US)
- Carl T. Hayden Veterans Affairs Medical Center (US)
- Yale University (US)
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-01-01
- Volume
- 32
- Issue
- 1
- Pages
- 187-192
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2606812
- OpenAlex
- W2181092548
- Cited by
- 881
- References
- 22
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 13 · 2023: 24 · 2022: 23 · 2021: 32 · 2020: 37 · 2019: 40 · 2018: 43 · 2017: 46 · 2016: 53 · 2015: 70 · 2014: 56 · 2013: 68 · 2012: 101
- FWCI
- 62.17
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- Amylin Pharmaceuticals
- Sanofi
- Edwards Lifesciences
- Osiris Therapeutics
- Insulet Corporation
- MannKind Corporation
- Halozyme
- Dexcom
- Tandem Diabetes Care
- Daiichi-Sankyo
- Novo Nordisk
- Pfizer Pharmaceuticals
- Daiichi Sankyo Company
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- tight glycemic control, cardiovascular events, type 1 diabetes, type 2 diabetes, microvascular complications, HbA1c targets, ACCORD trial, ADVANCE trial, Diabetes Control and Complications Trial, UKPDS, diabetic retinopathy, diabetic nephropathy, diabetic neuropathy, cardiovascular risk
- MeSH terms
- Adult, Aged, Blood Glucose, Cardiovascular Diseases, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Homeostasis, Humans, Hyperglycemia, Middle Aged, Risk Factors, Sensitivity and Specificity, Randomized Controlled Trials as Topic, Risk Assessment, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.